M. Takahashi, I. Hirota, T. Nakano et al.
Drug Metabolism and Pharmacokinetics 38 (2021) 100391
substrate recognition ability of hCE1 and hCE2 is characterized in
some substrates. However, it has not yet been investigated how
much the hydrolysis rate changes due to the difference in more
detailed structure and the difference in electron density of the ester.
In this study, we investigated the change in the hydrolysis rate of
hCE1 by focusing on the steric hindrance of the ester structure and
the electron density. Using indomethacin as a substrate, we syn-
thesized ester prodrugs with steric hindrance and alkoxy groups
with different electron densities, and we clarified the relationship
between these structures and the rate of hydrolysis.
2.3.2. General procedure for synthesis of 2ge2o, 3f and 4f
A mixture of indomethacin (1) (0.5 mmol), alcohol reagent
(0.75 mmol), EDC (0.75 mmol) and DMAP (0.05 mmol) in CH2Cl2
(5.0 mL) was stirred at room temperature under an argon atmo-
sphere for 1 day. After addition of 10% citric acid solution (5.0 mL),
the mixture was stirred for 5 min at the same temperature, and the
mixture was extracted with CH2Cl2 (20 mL). The organic solution
was dried over MgSO4 and evaporated under reduced pressure. The
residue was purified by column chromatography on SiO2 (ethyl
acetate/nehexane) to give an ester derivative 2.
2.3.3. General procedure for synthesis of 2t-2x
2. Materials and methods
A mixture of indomethacin (1) (0.5 mmol), alkyl halide reagent
(0.75 mmol), and Na2CO3 (1.5 mmol) in DMF (2.0 mL) was stirred at
room temperature under an argon atmosphere for 1 day. After
addition of H2O (20 mL), the mixture was extracted with hexane/
AcOEt (20 mL, 1/1). The organic solution was washed with H2O
(10 mL ꢀ 2) and brine (10 mL), dried over MgSO4 and evaporated
under reduced pressure. The residue was purified by column
chromatography on SiO2 (ethyl acetate/nehexane) to give an ester
derivative 2.
2.1. Reagents
Indomethacin was purchased from Tokyo Chemical Industry Co.,
Ltd. (Tokyo, Japan). Ester, amide and thioester derivatives were
synthesized by a condensing reaction using indomethacin (1). Butyl
p-hydroxybenzoate (BPHB) as the internal standard, alcohol re-
agents (2a: pentanol, 2b: hexan-2-ol, 2c: 2-methylpentanol, 2d: 3-
methylpentanol, 2e: 4-methylpentanol, 2f: phenol, 2g: 2-
methoxyphenol, 2h: 3-methoxyphenol, 2i: 4-methoxyphenol, 2j:
2-bromophenol, 2k: 3-bromophenol, 2l: 4-bromophenol, 2m: 20-
hydroxyacetphenone, 2n: 30-hydroxyacetphenone, 2o: 40-hydrox-
yacetphenone, 2p: 2-fluorophenol, 2q: 3-fluorophenol, 2r: 4-
fluorophenol, 2s: ethanol, 3f: aniline, 4f: thiophenol), alkyl halide
reagents (2t: chloromethyl pivalate, 2u: 3-bromophthalide, 2v: 1-
chloroethyl isopropyl carbonate, 2w: 1-chloroethyl cyclohexyl
carbonate, 2x: 4-chloromethyl-1,5-dimethyl-1,3-dioxol-2-one),
dicyclohexylcarbodiimide (DCC), 1-(3-dimethylaminopropyl)-3-
ethylcarbodiimide (EDC) and dimethylaminopyridine (DMAP)
were purchased from FUJIFILM Wako Pure Chemical Corporation
(Osaka, Japan). Human intestine microsomes (HIM) (7 doners,
mixed gender, 24e69 years old, Caucasian and African American),
human carboxylesterase 1b (hCES1b, hCE1) and hCE2 were pur-
chased from Corning inc. (MA, USA).
2.4. Enzyme reaction
2.4.1. p-Nitrophenyl acetate hydrolase activity
A typical incubation mixture (final volume of 1.0 mL) contained
10 mM Na,K phosphate buffer (pH 7.4) and 1 mM p-nitrophenyl
acetate (PNPA) (acetonitrile final concentration of 1.0% in the in-
cubation mixture) at 30 ꢁC. An enzyme source (0.05 mg/mL) was
added, and the PNPA hydrolase activity was measured spectro-
photometrically (detection at 405 nm) regarding the formation of
4-nitrophenol (ε ¼ 16400 Mꢂ1 cmꢂ1) at 30 ꢁC for 3 min, with data
obtained at 5-s intervals, using an Ultrospec 6300 pro (GE
Healthcare, formerly Amersham Bioscience, NJ, USA) [19].
2.4.2. General procedure for hydrolysis reaction
Solutions of indomethacin prodrugs (0.3125, 0.625, 1.25, 2.5, 5.0,
10 and 50 mM) were prepared in DMSO. A typical incubation
mixture (final volume of 100 mL) in 100 mM HEPES (pH 7.4) con-
2.2. Preparation of HLM samples
tained an enzyme (0.25 mg/mL) and 0.003125e0.5 mM of indo-
methacin prodrug (DMSO final concentration of 1.0% in the reaction
mixture). After 30emin incubation at 37 ꢁC, the reaction was
terminated by the addition of 0.3 mM BPHB in acetonitrile solution
Human liver microsomes (HLM) (single donor, male, 51 years
old, Caucasian) were prepared from human livers that were ob-
tained from the Human and Animal Bridging Research Organization
(HAB, Chiba, Japan), which is in partnership with the National
Disease Research Interchange (NDRI, Philadelphia, PA, USA). The
use of human livers was approved by the Ethics Committee of Chiba
Institute of Sciences (No. 22-1). The livers were homogenized and
centrifuged at 9,000 ꢀ G for 20 min at 4 ꢁC, and the supernatant
was ultra-centrifuged at 105,000 ꢀ G for 60 min at 4 ꢁC. The
microsome fraction was suspended in sucrose-EDTA-Tris (SET)
buffer (pH 7.4).
(100 mL) on an ice bath at 10 min. The mixture was centrifuged at
21,600 ꢀ G for 15 min at 4 ꢁC to precipitate the protein, and the
supernatant was subjected to HPLC analysis to determine
indomethacin.
2.5. Data analysis
2.5.1. Procedure for HPLC analysis
HPLC analyses were carried out using an LC solution (Shimadzu,
Kyoto, Japan) chromatographic system equipped with an LC-10AT
pump, SIL-20A auto sampler, CTO-10AS VP column oven, SPD-20A
UV/VIS detector, and SCL-10A VP system controller. Separations
2.3. Synthesis
2.3.1. General procedure for synthesis of 2ae2f, 2pe2r and 2s
A mixture of indomethacin (1) (0.5 mmol), alcohol reagent
(0.75 mmol), DCC (0.75 mmol) and DMAP (0.05 mmol) in CH2Cl2
(5.0 mL) was stirred at room temperature under an argon atmo-
sphere for 1 day. After addition of 10% citric acid solution (5.0 mL),
the mixture was stirred for 5 min at the same temperature, and the
mixture was extracted with CH2Cl2 (20 mL). The organic solution
was dried over MgSO4 and evaporated under reduced pressure. The
residue was purified by column chromatography on SiO2 (ethyl
acetate/nehexane) to give an ester derivative 2.
were performed on a column of Mightysil RP-18 GP 150-4.6 (5 mm)
(Cica-Reagent, Tokyo, Japan) at 30 ꢁC with detection at 254 nm.
Analytical HPLC was performed with elution at 1.0 mL/min using
MeOH with 0.1% H3PO4 aqueous solution ramped up from 65% to
90% over 25 min and then returned to 65% over 10 min. Analytical
HPLC was performed with BPHB as an internal standard
(tR ¼ 7.2 min). The enzyme activity was calculated from the area
ratio of indomethacin (tR ¼ 11.7 min) and BPHB. The Km and Vmax
values were calculated by the Michaelis-Menten equation using
nonlinear regression analysis with software (GraphPad Prism 7).
2